Travere Therapeutics (TVTX) Asset Utilization Ratio (2014 - 2026)
Travere Therapeutics' (TVTX) Asset Utilization Ratio came in at 0.87 for Q2 2026, up 44.4% from 0.60 a year earlier but down 5.5% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
For FY2025, Travere Therapeutics' Asset Utilization Ratio stood at 0.82, up 142.7% from FY2024.
- Annual Asset Utilization Ratio has increased for four consecutive years.
- In prior years, Travere Therapeutics' Asset Utilization Ratio was 0.34 in FY2024 (+69.7%), 0.20 in FY2023 (+31.6%), 0.15 in FY2022 (+771.2%) and 0.02 in FY2021 (-94.7%).
- Quarterly Asset Utilization Ratio has run from a low of 0.12 in Q3 2022 to a high of 0.92 in Q1 2026 over five years.
- On a year-over-year basis, Asset Utilization Ratio has increased in each of the last 12 quarters, with growth averaging 105.9% over the last eight quarters.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q4 2024, with growth of 137.0%; the weakest was Q3 2022, with a decline of 57.9%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.92 (Q1 2026), 0.86 (Q4 2025) and 0.80 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 0.47 |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn | 0.87 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.87 |
| Mar 31, 2026 | 0.92 |
| Dec 31, 2025 | 0.86 |
| Sep 30, 2025 | 0.80 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.48 |
| Dec 31, 2024 | 0.42 |
| Sep 30, 2024 | 0.39 |
| Jun 30, 2024 | 0.29 |
| Mar 31, 2024 | 0.21 |
| Dec 31, 2023 | 0.18 |
| Sep 30, 2023 | 0.17 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.16 |
| Sep 30, 2022 | 0.12 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.23 |
| Sep 30, 2021 | 0.29 |
API Access
Travere Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();